The aim of the meeting is to present preliminary and already obtained results of EUGeneHeart research and to jointly discuss the planning and adjustments for the coming 18 months within the General Assembly. Furthermore, administrative issues will be discussed during this meeting which can only be attended by invitation due to the presentation of confidential information such as of unpublished data and intellectual property. The meeting will be also attended by the responsible EU Officer and accompanied and supervised by members of the Scientific Advisory Board.